| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.001 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.001 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.001 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.002 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.09 | 0.003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.13 | 0.004 |